id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1109131,e3716adb-e53e-4d18-b5fd-b2ce6ad324fe,Q2,HOLLAND & KNIGHT LLP,18466,ALLIANCE FOR REGENERATIVE MEDICINE,2011,second_quarter,MED,"Advocate for funding for regenerative medicine companies and researchers in universities; Advocate for NIH funding for regenerative medicine research. Advocate for funding for the FDA.   Lobbied in support of HR 1862, The Regenerative Medicine Promotion Act of 2011.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE",80000,,0,0,2011-07-11T11:49:36.593000-04:00
1109132,e3716adb-e53e-4d18-b5fd-b2ce6ad324fe,Q2,HOLLAND & KNIGHT LLP,18466,ALLIANCE FOR REGENERATIVE MEDICINE,2011,second_quarter,BUD,Advocate for funding for regenerative medicine companies and researchers in universities; Advocate for NIH funding for regenerative medicine research.  Advocate for funding for the FDA.  Advocate for funding for NIST to develop manufacturing standards.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE",80000,,0,0,2011-07-11T11:49:36.593000-04:00
1109133,e3716adb-e53e-4d18-b5fd-b2ce6ad324fe,Q2,HOLLAND & KNIGHT LLP,18466,ALLIANCE FOR REGENERATIVE MEDICINE,2011,second_quarter,HCR,"Advocate for funding for regenerative medicine companies;  NIH funding for regenerative medicine research; funding for FDA to perform regulatory research and creation of federal coordinating entity for regenerative medicine.  Advocate for new/modified regulations re:  FDA aprroval of regenerative medicine products.  Met with NIST to explore collaborations re: manfacturing standards; Lobbied in support of HR 1862, The Regenerative Medicine Promotion Act of 2011","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE",80000,,0,0,2011-07-11T11:49:36.593000-04:00
1109134,e3716adb-e53e-4d18-b5fd-b2ce6ad324fe,Q2,HOLLAND & KNIGHT LLP,18466,ALLIANCE FOR REGENERATIVE MEDICINE,2011,second_quarter,SCI,Advocate for funding for regenerative medicine companies; Advocate for NIH funding for regenerative medicine research.  Advocate for new regulations re:  approval of regenerative medicine products.  Advocate for funding for the FDA.  Met with NIST officials on standards for reginerative medicine products. Advocate for assessment of federal regenerative medicine activities.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE",80000,,0,0,2011-07-11T11:49:36.593000-04:00